Determining the Effects of Ischemic Conditioning and Neuromuscular Electrical Stimulation on Overall Function After Lower Limb Amputation
2026年6月17日 更新者：University of Illinois at Chicago
Improving Muscle Strength and Function After Lower Limb Amputation
The goal of this clinical trial is to learn if ischemic conditioning and neuromuscular electrical stimulation improves muscle strength and walking behavior in those with limb loss. The main questions this trial aims to answer are:
Does neuromuscular electrical stimulation improve muscle strength and gait behavior in people who have a leg amputation?
Does neuromuscular electrical stimulation boost the effects of ischemic conditioning on muscle strength and gait behavior in people who have a leg amputation?
Researchers will compare the effects of neuromuscular electrical stimulation to ischemic conditioning to see if there are any significant differences between the impacts of each intervention. Also, researchers will use both interventions together to see if the interventions can boost each other's positive impacts on walking and function in people with leg amputation.
Participants will:
- Do ischemic conditioning OR neuromuscular electrical stimulation OR both interventions at home every other day for 2 weeks
- Visit the laboratory before and after completing interventions for the tests
- Visit the laboratory one week after the post intervention visit for follow-up tests
研究概览
研究类型
介入性
注册 (估计的)
24
阶段
- 不适用
联系人和位置
本节提供了进行研究的人员的详细联系信息，以及有关进行该研究的地点的信息。
学习联系方式
- 姓名：Nikou Nikoumanesh
- 电话号码：857-919-4211
- 邮箱：nniko@uic.edu
学习地点
-
-
Illinois
-
Chicago、Illinois、美国、60607
- University of Illinois Chicago
-
-
参与标准
研究人员寻找符合特定描述的人，称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
不
描述
Inclusion Criteria:
- Older than 18 years old
- History of unilateral transfemoral or transtibial amputation
- Able to ambulate independently without the use of aids (i.e., walking cane)
- Able to walk at least 6 minutes continuously without stopping.
- Has a safe residuum with no open wounds on either the residual or intact limb
- Has a prosthetic limb with materials that are sound and safe to withstand the mobility requirements of the study
Exclusion Criteria:
- Younger than 18 years old
- Inability to give informed consent
- Neurological disorder such as multiple sclerosis that affects gait
- Currently pregnant (or intend to become pregnant while participating in study)
- Blood clots in the leg, or any condition in which compression of the thigh or transient ischemia is contraindicated (e.g. open wounds in the leg)
- History of uncontrolled hypertension
- History of heart failure
- Implanted electrical device such as a pacemaker or defibrillator
- Head injury within the previous 6 months
- Seizure disorder
- History of thrombosis
- History of sickle cell trait
- History of genetic disease that impacts gait (e.g. cerebral palsy, muscular dystrophy).
学习计划
本节提供研究计划的详细信息，包括研究的设计方式和研究的衡量标准。
研究是如何设计的？
设计细节
- 主要用途：治疗
- 分配：随机化
- 介入模型：并行分配
- 屏蔽：无（打开标签）
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
有源比较器：Ischemic Conditioning
|
A blood pressure cuff will be used for ischemic conditioning, which is a non-invasive intervention that involves episodes of muscle ischemia (restriction of blood flow) followed by reperfusion (restoration of blood flow).
|
|
实验性的：Neuromuscular Electrical Stimulation
|
Neuromuscular electrical stimulation delivers intermittent electrical impulses to peripheral nerves, inducing involuntary muscle contractions.
|
|
实验性的：Neuromuscular Electrical Stimulation + Ischemic Conditioning
|
A blood pressure cuff will be used for ischemic conditioning, which is a non-invasive intervention that involves episodes of muscle ischemia (restriction of blood flow) followed by reperfusion (restoration of blood flow).
Neuromuscular electrical stimulation delivers intermittent electrical impulses to peripheral nerves, inducing involuntary muscle contractions.
|
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change from baseline in the self-selected gait speed (m/s) at week 3 and 4
大体时间：From enrollment to the end of treatment (post-testing) and follow-up, at 4 weeks of participation
|
Participants will be asked to walk at their self-selected gait speed (m/s) for 6 minutes on a split-belt treadmill at the 1st, 9th, and 10th visits.
The change in gait speed from the first visit will be calculated by SPSS v. 31.0
|
From enrollment to the end of treatment (post-testing) and follow-up, at 4 weeks of participation
|
|
Change from baseline in the hip's isometric muscle strength (N.m/kg) using a handheld dynamometer at the 3rd and 4th weeks.
大体时间：From enrollment to the end of treatment (post-testing) and follow-up, at 4 weeks of participation
|
Participants will be positioned supine on a treatment table with a neutral position (legs shoulder-width apart) and will hold their arms by their chest.
The handheld dynamometer will be placed at 20 centimeters distal to the greater trochanter.
For participants with shorter residual limbs, the lever arm will be adjusted, and the handheld dynamometer will be placed on the distal side of the residual limb.
Participants will be asked to perform three maximal contractions for 3 to 5 seconds with a 1-minute rest interval for each limb.
The highest score of the three maximal contractions will be used for analysis.
During all strength measurements, verbal encouragement will be given.
|
From enrollment to the end of treatment (post-testing) and follow-up, at 4 weeks of participation
|
|
Changes from baseline in gait kinematics (angle) through gait motion analysis at 3rd and 4th weeks
大体时间：From enrollment to the end of treatment (post-testing) and follow-up, at 4 weeks of participation
|
Participants will be asked to walk at their self-selected gait speed for 6 minutes on a split-belt treadmill during their 1st, 9th, and 10th visits.
The changes in gait kinematics (angle) at the ankle, knee, hip joints, and trunk will be analyzed using waveform analysis from the first visit.
|
From enrollment to the end of treatment (post-testing) and follow-up, at 4 weeks of participation
|
|
Changes from baseline in gait kinetics (N.m) through gait motion analysis at 3rd and 4th weeks
大体时间：From enrollment to the end of treatment (post-testing) and follow-up, at 4 weeks of participation
|
Participants will be asked to walk at their self-selected gait speed for 6 minutes on a split-belt treadmill during their 1st, 9th, and 10th visits.
The changes in gait kinetics (N.m) at the ankle, knee, hip joints, and trunk will be analyzed using waveform analysis from the first visit.
|
From enrollment to the end of treatment (post-testing) and follow-up, at 4 weeks of participation
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Changes from baseline in daily mobility tasks (%) using the Prosthetic Limb Users Survey of Mobility short form at the 3rd and 4th weeks
大体时间：From enrollment to the end of treatment (post-testing) and follow-up, at 4 weeks of participation
|
-Prosthetic Limb Users Survey of Mobility short form is a validated, patient-reported outcome measure used to assess the mobility of adults with lower limb amputations.
It takes about 2 minutes to complete and is widely.
Responses are converted into a standardized T-score.
A score of 50 represents the average mobility of a prosthetic limb user.
|
From enrollment to the end of treatment (post-testing) and follow-up, at 4 weeks of participation
|
|
Changes from baseline in average number of daily steps using an activity monitor at the 3rd and 4th weeks
大体时间：From enrollment to the end of treatment (post-testing) and follow-up, at 4 weeks of participation
|
Participants will wear an activity monitor to assess daily steps.
We will compare the average daily steps before and after receiving the assigned interventions.
|
From enrollment to the end of treatment (post-testing) and follow-up, at 4 weeks of participation
|
|
Changes from baseline in the mean seated systolic and diastolic blood pressure (mmHg) at 3rd and 4th weeks
大体时间：From enrollment to the end of treatment (post-testing) and follow-up, at 4 weeks of participation
|
From enrollment to the end of treatment (post-testing) and follow-up, at 4 weeks of participation
|
|
|
Changes from baseline in walking economy (mlO₂ /kg.min) at 3rd and 4th weeks
大体时间：From enrollment to the end of treatment (post-testing) and follow-up, at 4 weeks of participation
|
Participants will be asked to walk while wearing a silicone face mask at their self-selected gait speed for 6 minutes on a split-belt treadmill during their 1st, 9th, and 10th visits.
Changes in walking economy (ml O₂/kg/min) will be analyzed by assessing the amount of oxygen used (ml O₂), normalized for both body weight (kg) and walking duration (min).
|
From enrollment to the end of treatment (post-testing) and follow-up, at 4 weeks of participation
|
|
Changes from baseline in the carotid-femoral pulse wave velocity (m/s) at the 3rd and 4th weeks
大体时间：From enrollment to the end of treatment (post-testing) and follow-up, at 4 weeks of participation
|
Participants will be asked to lay supine on a treatment table for 15 minutes so that blood pressure and cardiac function are similar to basal resting condition for repeatability and to minimize noise.
Central blood pressure and arterial stiffness will be measured using the SphygmoCor.
Carotid-femoral pulse wave velocity is a measure of the time for the arterial pulse to circulate from the carotid to the femoral artery and is considered the gold standard for arterial stiffness measure.
We will measure waveforms on the same side as the intact limb.
All measurements will be made in duplicate and averaged, or triplicate if the difference between two measures is greater than 0.5m/s.
|
From enrollment to the end of treatment (post-testing) and follow-up, at 4 weeks of participation
|
|
Changes from baseline in socket comfort score (out f 10) at the 3rd and 4th weeks
大体时间：From enrollment to the end of treatment (post-testing) and follow-up, at 4 weeks of participation
|
The Prosthetic Socket Fit Comfort Score is a validated, 11-point self-report scale (ranging from 0 to 10) used by individuals with amputations and their prosthetists to measure and track the comfort of an artificial limb.
O represents the most uncomfortable socket fit, and 10 represents the most comfortable socket fit.
|
From enrollment to the end of treatment (post-testing) and follow-up, at 4 weeks of participation
|
|
Changes from baseline in quality of life (%) using Nottingham Health Profile at the 3rd and 4th weeks
大体时间：From enrollment to the end of treatment (post-testing) and follow-up, at 4 weeks of participation
|
Nottingham Health Profile is a patient-reported questionnaire designed to measure subjective, health-related quality of life.
It takes about 5 minutes to complete and requires simple "yes" or "no" answers.
Scores are calculated using a weighted algorithm and range from 0 (no distress) to 100 (maximum distress).
|
From enrollment to the end of treatment (post-testing) and follow-up, at 4 weeks of participation
|
|
Changes from baseline in the Activities-specific Balance Confidence Scale (%) at the 3rd and 4th weeks
大体时间：From enrollment to the end of treatment (post-testing) and follow-up, at 4 weeks of participation
|
The Activities-specific Balance Confidence Scale: For each of the specified activities, participants will indicate the level of confidence in doing the activity without losing their balance or becoming unsteady by choosing one of the percentage points on the scale from 0% (No Confidence) to 100% (Completely Confident)
|
From enrollment to the end of treatment (post-testing) and follow-up, at 4 weeks of participation
|
|
Changes from baseline in Oswestry Low Back Pain (%) at the 3rd and 4th weeks
大体时间：From enrollment to the end of treatment (post-testing) and follow-up, at 4 weeks of participation
|
Oswestry Low Back Pain is widely considered the "gold standard" for measuring how lower back or leg pain impacts a patient's daily functional abilities.
This test consists of 10 sections evaluating different aspects of daily living.
For each category, the participant will select the single statement that best describes their situation.
|
From enrollment to the end of treatment (post-testing) and follow-up, at 4 weeks of participation
|
|
Changes from baseline in the average sedentary time (s) using an activity monitor at the 3rd and 4th weeks
大体时间：From enrollment to the end of treatment (post-testing) and follow-up, at 4 weeks of participation
|
Participants will wear an activity monitor to calculate the sedentary time (s) per day.
We will compare the average sedentary time before and after receiving the assigned interventions.
|
From enrollment to the end of treatment (post-testing) and follow-up, at 4 weeks of participation
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查，以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (估计的)
2026年7月1日
初级完成 (估计的)
2027年8月30日
研究完成 (估计的)
2027年12月1日
研究注册日期
首次提交
2026年6月4日
首先提交符合 QC 标准的
2026年6月17日
首次发布 (实际的)
2026年6月24日
研究记录更新
最后更新发布 (实际的)
2026年6月24日
上次提交的符合 QC 标准的更新
2026年6月17日
最后验证
2026年6月1日
更多信息
与本研究相关的术语
其他研究编号
- 2026_0262
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)？
不
药物和器械信息、研究文件
研究美国 FDA 监管的药品
不
研究美国 FDA 监管的设备产品
是的
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.